Your browser doesn't support javascript.
loading
A Randomized, Open-Label Phase 2 Study of the CXCR4 Inhibitor LY2510924 in Combination with Sunitinib Versus Sunitinib Alone in Patients with Metastatic Renal Cell Carcinoma (RCC).
Hainsworth, John D; Reeves, James A; Mace, Joseph R; Crane, Edward J; Hamid, Oday; Stille, John R; Flynt, Amy; Roberson, Stephanie; Polzer, John; Arrowsmith, Edward R.
Afiliação
  • Hainsworth JD; Sarah Cannon Research Institute/Tennessee Oncology, PLLC, 250 25th Ave N #100, Nashville, TN, 37203, USA. John.Hainsworth@scresearch.net.
  • Reeves JA; Florida Cancer Specialists, Fort Myers, FL, USA.
  • Mace JR; Florida Cancer Specialists, St. Petersburg, FL, USA.
  • Crane EJ; Oncology Hematology Care, Cincinnati, OH, USA.
  • Hamid O; Eli Lilly and Company, Indianapolis, IN, USA.
  • Stille JR; Eli Lilly and Company, Indianapolis, IN, USA.
  • Flynt A; PharPoint Research Inc, Durham, NC, USA.
  • Roberson S; Eli Lilly and Company, Indianapolis, IN, USA.
  • Polzer J; Eli Lilly and Company, Indianapolis, IN, USA.
  • Arrowsmith ER; Tennessee Oncology, Chattanooga, TN, USA.
Target Oncol ; 11(5): 643-653, 2016 10.
Article em En | MEDLINE | ID: mdl-27154357
Assuntos
Buscar no Google
Imprimir
XML
PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos Cíclicos / Pirróis / Receptores CXCR4 / Indóis Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Buscar no Google
Imprimir
XML
PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos Cíclicos / Pirróis / Receptores CXCR4 / Indóis Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Aged / Female / Humans / Male Idioma: En Ano de publicação: 2016 Tipo de documento: Article